Search Results - "Whitehall, Kaleigh"

Systematic literature review of the somatic comorbidities experienced by adults with phenylketonuria by Whitehall, Kaleigh B, Rose, Sarah, Clague, Gillian E, Ahring, Kirsten K, Bilder, Deborah A, Harding, Cary O, Hermida, Álvaro, Inwood, Anita, Longo, Nicola, Maillot, François, Muntau, Ania C, Pessoa, André L S, Rocha, Júlio C, Rohr, Fran, Sivri, Serap, Said, Jack, Oshinbolu, Sheun, Sibbring, Gillian C

“…Phenylketonuria (PKU) is an inborn error of phenylalanine (Phe) metabolism that, if untreated, causes Phe accumulation in the brain leading to neurophysiologic…”
Get full text

Meta-analysis of bone mineral density in adults with phenylketonuria by Rocha, Júlio C, Hermida, Álvaro, Jones, Cheryl J, Wu, Yunchou, Clague, Gillian E, Rose, Sarah, Whitehall, Kaleigh B, Ahring, Kirsten K, Pessoa, André L S, Harding, Cary O, Rohr, Fran, Inwood, Anita, Longo, Nicola, Muntau, Ania C, Sivri, Serap, Maillot, François

“…Lifelong management of phenylketonuria (PKU) centers on medical nutrition therapy, including dietary phenylalanine (Phe) restriction in addition to Phe-free or…”
Get full text

Long-term preservation of intellectual functioning in sapropterin-treated infants and young children with phenylketonuria: A seven-year analysis by Waisbren, Susan, Burton, Barbara K., Feigenbaum, Annette, Konczal, Laura L., Lilienstein, Joshua, McCandless, Shawn E., Rowell, Richard, Sanchez-Valle, Amarilis, Whitehall, Kaleigh B., Longo, Nicola

“…Sapropterin dihydrochloride has been approved for the treatment of hyperphenylalaninemia in infants and young children with phenylketonuria (PKU). Sapropterin…”
Get full text

Pegvaliase for the treatment of phenylketonuria: Final results of a long-term phase 3 clinical trial program by Harding, Cary O., Longo, Nicola, Northrup, Hope, Sacharow, Stephanie, Singh, Rani, Thomas, Janet A., Vockley, Jerry, Zori, Roberto T., Bulloch Whitehall, Kaleigh, Lilienstein, Joshua, Lindstrom, Kristin, Levy, Drew G., Jones, Shaun, Burton, Barbara K.

“…Phenylketonuria (PKU) is a genetic disorder caused by deficiency of the enzyme phenylalanine hydroxylase (PAH), which results in phenylalanine (Phe)…”
Get full text

Use of pegvaliase in the management of phenylketonuria: Case series of early experience in US clinics by Adams, Darius, Andersson, Hans C., Bausell, Heather, Crivelly, Kea, Eggerding, Caroline, Lah, Melissa, Lilienstein, Joshua, Lindstrom, Kristin, McNutt, Markey, Ray, Joseph W., Saavedra, Heather, Sacharow, Stephanie, Starin, Danielle, Tiffany-Amaro, Jennifer, Thomas, Janet, Vucko, Erika, Wessenberg, Leah B., Whitehall, Kaleigh

“…To present a case series that illustrates real-world use of pegvaliase based on the initial experiences of US healthcare providers. Sixteen healthcare…”
Get full text

Real-world treatment, dosing, and discontinuation patterns among patients treated with pegvaliase for phenylketonuria: Evidence from dispensing data by Lah, Melissa, Cook, Keziah, Gomes, Dumingu Aparna, Liu, Stephanie, Tabatabaeepour, Nadia, Kirson, Noam, Chen, Er, Lindstrom, Kristin, Whitehall, Kaleigh Bulloch, Van Backle, Joost, Burton, Barbara K.

“…Phenylketonuria (PKU) is an inborn metabolic error characterized by a deficiency of the enzyme required for the metabolism of phenylalanine, an essential amino…”
Get full text

P032: Systematic literature review of the prevalence and severity of somatic comorbidities in adults with phenylketonuria by Whitehall, Kaleigh Bulloch, Rose, Sarah, Clague, Gillian, Ahring, Kirsten, Bilder, Deborah, Harding, Cary, Hermida, Álvaro, Inwood, Anita, Longo, Nicola, Maillot, François, Muntau, Ania, Pessoa, André Santos, Rocha, Júlio César, Rohr, Fran, Sivri, H. Serap, Said, Jack, Oshinbolu, Sheun, Sibbring, Gillian

Get full text

EFFICACY AND SAFETY OF THE RECOMMENDED PEGVALIASE DOSING REGIMEN IN ADULTS WITH PHENYLKETONURIA IN THE PHASE 3 PRISM STUDIES by Sacharow, Stephanie, Northrup, Hope, Whitehall, Kaleigh Bulloch, Rowell, Richard, Lindstrom, Kristin, Burton, Barbara, Thomas, Janet

Get full text

Evaluating change in diet with pegvaliase treatment in adults with phenylketonuria: Analysis of phase 3 clinical trial data by Rohr, Fran, Burton, Barbara, Dee, Anne, Harding, Cary O., Lilienstein, Joshua, Lindstrom, Kristin, MacLeod, Erin, Rose, Sarah, Singh, Rani, van Calcar, Sandra, Whitehall, Kaleigh

“…Phenylketonuria (PKU), a genetic disorder characterized by phenylalanine hydroxylase (PAH) deficiency and phenylalanine (Phe) accumulation, is primarily…”
Get full text